Low-dose methotrexate safety in dermatologic disease: incidence and timing of laboratory abnormalities during the first year of therapy
Greiling, Teri; Hajar, T.; Latour, E.J.; Haynes, D.; Topham, C.; Hill, E.; Strunck, J.; Simpson, E.L.
2020

Files

Abstract

Methotrexate is a commonly used medication for inflammatory and autoimmune disorders. Dermatologic literature recommends frequent laboratory monitoring due to the potential of serious side effects although data supporting this recommendation is lacking. In this study, we aimed to identify the incidence and timing of laboratory abnormalities in a cohort of patients prescribed low-dose methotrexate during their first year of therapy.

Details

Title
Low-dose methotrexate safety in dermatologic disease: incidence and timing of laboratory abnormalities during the first year of therapy
Creator
Greiling, Teri : Oregon Health and Science University
Hajar, T. : Oregon Health and Science University
Latour, E.J. : Oregon Health and Science University
Haynes, D. : Oregon Health and Science University
Topham, C. : Oregon Health and Science University
Hill, E. : Oregon Health and Science University
Strunck, J. : Oregon Health and Science University
Simpson, E.L. : Oregon Health and Science University
Meeting Name
Research Week, Oregon Health and Science University, 2020
Publisher
Oregon Health and Science University
Date
2020
Subjects
Keywords
DOI
https://doi.org/10.6083/cn69m494r
Content Type
Abstract
Department
Department of Dermatology
School
School of Medicine
Copyright Status
In copyright - joint owners
Usage Statement
Record ID
8336
Record Created
2023-06-29
Record Appears in
Organizations > Departments and Divisions > School of Medicine Clinical Sciences Departments and Divisions > Department of Dermatology
Organizations > Schools > School of Medicine
OHSU Works > Events > Research Week
All Records

PDF

Statistics

from
to
Export
Download Full History